↑Rubio-Póo C, Lemini C, García-Mondragón J, de la Peña A, Jayme V, Mendoza-Patiño N, etal. (February 1990). "The anticoagulant effect of hexolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect". Steroids. 55 (2): 83–86. doi:10.1016/0039-128x(90)90030-f. PMID2326832. S2CID32937513.
↑Rubio-Póo C, Lemini C, Silva G, García-Mondragón J, Zavala E, Castro D, etal. (1993). "Comparison of the time course of anticoagulant and estrogenic effects of prolame, butolame, pentolame and hexolame, a homologous series of 17 beta-amino estrogens". Proceedings of the Western Pharmacology Society. 36: 143–147. PMID8378368.